Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Enjosim logo — Pioneering the future of biomacromolecule delivery with high...

Enjosim

Pioneering the future of biomacromolecule delivery with high-precision injectors for advanced pharmaceuticals.

Founded 2021 Seed Biopharma, Medical Devices

General Information

Company Name Enjosim
Founded Year 2021
Industries Biopharma, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Enjosim. To contact Enjosim, visit enjosim.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Enjosim

Enjosim, a biopharma startup founded in 2021, is pioneering the future of biomacromolecule delivery with high-precision injectors for advanced pharmaceuticals. The company's slogan reflects its commitment to innovating in drug delivery technologies. Enjosim focuses on the research, development, production, and marketing of autonomous delivery systems, especially those catered to biomacromolecule pharmaceuticals. The company currently offers a range of high-precision pen injectors designed for biologics such as insulin, growth hormones, and GLP-1. The most recent development for Enjosim was its Seed Round investment at 15 January 2024, marked by an investment from Lightspeed China Partners. This backing showcases investor confidence in the potential of Enjosim's technology and its future impact on the biopharma industry. With a focus on precision and innovation, Enjosim's contributions to the biopharma industry have the potential to reshape the landscape of biomacromolecule drug delivery. As the company continues to grow and develop its products, its partnerships and investments will play a crucial role in shaping its future trajectory and market impact.

Taxonomy: biomacromolecule delivery, pharmaceuticals, injectors, autonomous delivery systems, biologics, insulin delivery, growth hormone delivery, GLP-1 delivery, high-precision pen injectors, R&D, sales, self-delivery systems, biomacromolecule pharmaceuticals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Lightspeed China Partners
Lightspeed China Partners
15 Jan 2024

Enjosim Alternatives & Competitors

View All Alternatives
Enjosim vs
Promea Therapeutics
Promea Therapeutics India

Your Health. Our Promise.

210 employees
Biopharma, Biotechnology
Enjosim vs
Cullinan Therapeutics
Cullinan Therapeutics United States

Science That Moves

Post-IPO Equity
131 employees
Biopharma, Biotechnology
Enjosim vs
RainPhil Inc
RainPhil Inc Philippines

Together, our customers will achieve more

60 employees
Biopharma, Health Care
View all alternatives

FAQ About Enjosim

Pioneering the future of biomacromolecule delivery with high-precision injectors for advanced pharmaceuticals.
Enjosim was founded in 2021.
Enjosim operates in Biopharma and Medical Devices. Its work centres on biomacromolecule delivery, pharmaceuticals, injectors and autonomous delivery systems.
Enjosim has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Enjosim include Promea Therapeutics, Cullinan Therapeutics, RainPhil Inc, Inoviv, Torrey Pines Law Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Enjosim and Promea Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Enjosim, https://bouncewatch.com/company/enjosim, updated 2 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes